New patent for Catalyst Pharms drug AGAMREE

Annual Drug Patent Expirations for AGAMREE Agamree is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from two suppliers. The generic ingredient in…

The post New patent for Catalyst Pharms drug AGAMREE appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog